ELAN
Elanco Animal Health Incorporated Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Elanco Animal Health (ELAN) Stock: Buy, Sell, or Hold?
$26.50
+0.02 (+0.08%)
▲
5d:
+11.91%
30d:
+17.52%
90d:
+11.96%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 06, 2026
0d
Protect ELAN Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (22%)
Quality Score
27/100
Position
EXTENDED
30-Day Fair Range
$22.20 – $25.11
Position: EXTENDED
Forward P/E & Valuation
20.5x
FAIR
vs 20.3x historical avg
Wall Street Target
$31.00
+17.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$22.93 / $27.29
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELAN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ELAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.87
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$22.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELAN is currently trading at $26.50, which is considered extended relative to its 30-day fair value range of $22.20 to $25.11. The stock's valuation (Forward PE: 20.5) is in line with its historical norms (20.3). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ELAN is in a downtrend. The price is approaching resistance at $27.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELAN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.00 (+17.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELAN is in a downtrend. The price is approaching resistance at $27.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELAN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.00 (+17.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.20 -
$25.11
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.4%
Trading Range & Key Levels
30-Day Trading Range
$22.20 -
$25.11
Current vs Trading Range
EXTENDED
Support Level
$22.93
Resistance Level
$27.29
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding ELAN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+5.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($31.00)
- NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
20.53
Wall Street Target
$31.00
(+17.0%)
Revenue Growth (YoY)
11.3%
Earnings Growth (YoY)
440.5%
Profit Margin
-2.9%
Valuation Premium vs History
+0.4% premium
PE vs Historical
20.5 vs 20.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$26.61
(+0%)
2-Year Target
$26.71
(+1%)
3-Year Target
$26.82
(+1%)
3-Yr Target (if PE normalizes)
(PE: 21→20)
PE COMPRESSION
$26.52
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.5, Growth: 9.0%)
$34.30
(+29%)
Base:
(SPY PE: 19.9, Growth: 9.0%)
$33.18
(+25%)
Bear:
(PE: 16.9, Growth: 9.0%)
$28.20
(+6%)
Share ELAN Analysis
Share this live ELAN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELAN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Elanco Animal Health reported strong Q3 revenue growth of 11% YoY, according to StockTwits messages and delayed data from It's All About The Options. No recent news articles were found on Yahoo Finance.
Key Retail Themes:
Revenue Growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:58 AM ET
Data refreshes hourly during market hours. Next update: 4:58 AM
Data refreshes hourly during market hours. Next update: 4:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Advanced ELAN Option Strategies
Professional options setups generated by AI based on today's ELAN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELAN Research Pages
